13 related articles for article (PubMed ID: 38715679)
1. More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved?
Tong WH; Mertens BJ
J Clin Oncol; 2023 May; 41(13):2450-2451. PubMed ID: 36898080
[No Abstract] [Full Text] [Related]
2. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Laetsch TW; Maude SL; Rives S; Hiramatsu H; Bittencourt H; Bader P; Baruchel A; Boyer M; De Moerloose B; Qayed M; Buechner J; Pulsipher MA; Myers GD; Stefanski HE; Martin PL; Nemecek E; Peters C; Yanik G; Khaw SL; Davis KL; Krueger J; Balduzzi A; Boissel N; Tiwari R; O'Donovan D; Grupp SA
J Clin Oncol; 2023 Mar; 41(9):1664-1669. PubMed ID: 36399695
[No Abstract] [Full Text] [Related]
3. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621.
O'Brien MM; Ji L; Shah NN; Rheingold SR; Bhojwani D; Yuan CM; Xu X; Yi JS; Harris AC; Brown PA; Borowitz MJ; Militano O; Kairalla J; Devidas M; Raetz EA; Gore L; Loh ML
J Clin Oncol; 2022 Mar; 40(9):956-967. PubMed ID: 35007127
[TBL] [Abstract][Full Text] [Related]
4. Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.
Locatelli F; Zugmaier G; Mergen N; Bader P; Jeha S; Schlegel PG; Bourquin JP; Handgretinger R; Brethon B; Rössig C; Kormany WN; Viswagnachar P; Chen-Santel C
Blood Adv; 2022 Feb; 6(3):1004-1014. PubMed ID: 34979020
[TBL] [Abstract][Full Text] [Related]
5. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
6. Pediatric acute lymphoblastic leukemia.
Inaba H; Mullighan CG
Haematologica; 2020 Nov; 105(11):2524-2539. PubMed ID: 33054110
[TBL] [Abstract][Full Text] [Related]
7. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Maude SL; Laetsch TW; Buechner J; Rives S; Boyer M; Bittencourt H; Bader P; Verneris MR; Stefanski HE; Myers GD; Qayed M; De Moerloose B; Hiramatsu H; Schlis K; Davis KL; Martin PL; Nemecek ER; Yanik GA; Peters C; Baruchel A; Boissel N; Mechinaud F; Balduzzi A; Krueger J; June CH; Levine BL; Wood P; Taran T; Leung M; Mueller KT; Zhang Y; Sen K; Lebwohl D; Pulsipher MA; Grupp SA
N Engl J Med; 2018 Feb; 378(5):439-448. PubMed ID: 29385370
[TBL] [Abstract][Full Text] [Related]
8. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Grupp SA; Kalos M; Barrett D; Aplenc R; Porter DL; Rheingold SR; Teachey DT; Chew A; Hauck B; Wright JF; Milone MC; Levine BL; June CH
N Engl J Med; 2013 Apr; 368(16):1509-1518. PubMed ID: 23527958
[TBL] [Abstract][Full Text] [Related]
10. Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia.
Nakayama H
Transl Pediatr; 2024 Apr; 13(4):535-536. PubMed ID: 38715679
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
